GSK3B and malignant colon neoplasm: In DLD-1 and LS174T colon cancer cells, activation of the EP2 receptor by PGE2 promotes the release of glycogen synthase kinase 3β (GSK-3β) from the adenomatous polyposis coli (APC)/Axin/β-catenin complex [19].